History | Avelumab with axitinib for untreated advanced renal cell carcinoma | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 140 KB)

Published:

28 August 2020

Final draft guidance

Final draft guidance
Final appraisal document (PDF 294 KB)

Published:

31 July 2020
Committee papers (PDF 6.73 MB)

Published:

31 July 2020
Committee papers (PDF 454 KB)

Published:

31 July 2020
Public committee slides (PDF 1.71 MB)

Published:

31 July 2020

Invitation to participate

Final scope (PDF 180 KB)

Published:

15 May 2019
Equality impact assessment (Scoping) (PDF 120 KB)

Published:

15 May 2019
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 257 KB)

Published:

17 May 2019
Final stakeholder list (PDF 187 KB)

Published:

17 May 2019

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 333 KB)

Published:

12 February 2019
Draft matrix post referral (PDF 261 KB)

Published:

18 February 2019